CSIMarket
 
Novo Integrated Sciences Inc   (NVOS)
Other Ticker:  
 
 
Price: $0.5500 $0.00 -0.883%
Day's High: $0.6365 Week Perf: 1.83 %
Day's Low: $ 0.54 30 Day Perf: -19.81 %
Volume (M): 887 52 Wk High: $ 2.12
Volume (M$): $ 488 52 Wk Avg: $0.46
Open: $0.55 52 Wk Low: $0.07



 Market Capitalization (Millions $) 9
 Shares Outstanding (Millions) 17
 Employees -
 Revenues (TTM) (Millions $) 7
 Net Income (TTM) (Millions $) 14
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Novo Integrated Sciences Inc
Novo Integrated Sciences Inc is a publicly-traded company based in Vancouver, Canada. They provide healthcare services and products aimed at improving patient outcomes and reducing healthcare costs. Novo Integrated Sciences operates through two main divisions: Novo Healthnet Limited and Novo Healthnet Rehabilitation Limited. The company's services include chronic pain management, rehabilitation, and diagnostic imaging. Novo Integrated Sciences aims to build a network of integrated healthcare clinics and partner with existing healthcare providers to deliver high-quality care.


   Company Address: 11120 NE 2nd Street Bellevue 98004 WA
   Company Phone Number: 617-9797   Stock Exchange / Ticker: NASDAQ NVOS
   NVOS is expected to report next financial results on April 02, 2024.


Customers recorded net loss Customers recorded net loss



• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ALSN        1.09% 
BC   -2.73%    
BWA   -1.44%    
CMI        6.06% 
OMTK        6.06% 
THRM   -2.6%    
• View Complete Report
   



Novo Integrated Sciences Inc

Novo Integrated Sciences Inc Faces Share Price Decline and Financial Loss in First Quarter of 2024



Novo Integrated Sciences Inc, an established company traded on the NASDAQ, recently experienced a significant decline in share prices. With a -2.72% decrease in February 2024, the company's shares have plummeted by -56.06% over the past 90 days. Alongside this decline, Novo Integrated Sciences Inc released its financial results for the first quarter of 2024, revealing a substantial loss per share, decreased earnings, and a noticeable buildup in inventories and accounts receivable.
1. Declining Earnings:
During the first quarter of 2024, Novo Integrated Sciences Inc incurred a loss per share of $-0.28. This is in stark contrast to the previous year's first quarter, where the loss per share only amounted to $-0.12. Additionally, the company witnessed a significant decrease in earnings compared to the prior quarter, as earnings per share fell from $2.47 to $-0.28.
Implication:
The declining earnings raise concerns about the company's financial stability and efficiency. These poor financial results could negatively impact investor sentiment and lead to further declines in share prices.






 

Novo Integrated Sciences Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com